Author archives: Thomas Hughes

Accolade (NASDAQ: ACCD) is certainly an interesting play on the health care space providing business and employee services geared toward helping clients navigate the cumbersome health benefits arena. The pandemic…

RH (NYSE: RH) was one of the biggest winners from the pandemic boom and now it is one of the biggest losers of the pandemic bust. More importantly, because of…

McCormick & Company (NYSE: MKC) is a high-quality consumer staple stock and a healthy dividend payer so it should be a good defensive play for the times. The problem is…

Goldman Sachs analysts Ben Snyder issued a letter to investors echoing a sentiment we share. In his note, he says the 2023 outlook for S&P 500 (NYSEARCA: SPY) earnings is…

H.B. Fuller has proven to be inflation-proof if nothing else. The company manufactures adhesive chemicals for 3 end markets and the demand is high despite a series of pricing increases….

Shares of FedEx (NYSE: FDX) soared in the wake of the Q4 earnings and they look like they will move even higher but the gains will likely be capped at…

Carmax (NYSE: KMX) stock is geared for higher prices, the question is how high will they go? While the Q1 results were better than expected, several factors will weigh on…

The 27 analysts covering Adobe (NASDAQ: ADBE) still rate it a solid Buy but we don’t think now is the time to start buying. While the Buy rating has held…

The outlook for the Q2 earnings reporting season is about as cloudy as it could be. Between uncertain supply chain improvement, wildly out-of-control inflation, rising energy prices, and an aggressive…

When Target (NYSE: TGT) warned the market its Q2 earnings could fall short it was dire news for the market. The idea that inventories were bloating, sales were slowing, and…